|
Volumn 9, Issue 7, 2004, Pages
|
Ciclopirox (Loprox) gel for superficial fungal infections.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIFUNGAL AGENT;
CICLOPIROX;
PYRIDONE DERIVATIVE;
CANADA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DERMATOMYCOSIS;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
GEL;
HOSPITALIZATION;
HUMAN;
MALE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TOPICAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
ADMINISTRATION, TOPICAL;
ANTIFUNGAL AGENTS;
CANADA;
DERMATOMYCOSES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GELS;
HUMANS;
MALE;
PROGNOSIS;
PYRIDONES;
RANDOMIZED CONTROLLED TRIALS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 4544297216
PISSN: 12015989
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (12)
|
References (13)
|